You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucopolysaccharidosis VII

Showing 51 - 75 of 245
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucopolysaccharidosis VI Clinical Surveillance Program

Completed
  • Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)
    • Irvine, California
    • +49 more
    Apr 2, 2021

    Mucopolysaccharidosis Type IIIB

    Completed
    • Sanfilippo Syndrome Type B
      • Oakland, California
      • +3 more
      Mar 15, 2021

      Mucopolysaccharidosis Type II, Metabolic Diseases Trial in Russian Federation (GNR-055 1.0-2.0-3.0 mg/kg, GNR-055 2.0 mg/kg,

      Recruiting
      • Mucopolysaccharidosis Type II
      • Metabolic Diseases
      • GNR-055 1.0-2.0-3.0 mg/kg
      • +2 more
      • Ekaterinburg, Russian Federation
      • +4 more
      Jan 13, 2022

      Mucopolysaccharidosis Type IIIA Trial in Worldwide (LYS-SAF302)

      Active, not recruiting
      • Mucopolysaccharidosis Type IIIA
      • Orange, California
      • +7 more
      Aug 30, 2021

      Mucopolysaccharidosis II Trial in Worldwide (Iduronate-2-sulfatase enzyme replacement therapy, iduronate-2-sulfatase enzyme

      Completed
      Has Results
      • Mucopolysaccharidosis II
      • Iduronate-2-sulfatase enzyme replacement therapy
      • +2 more
      • Oakland, California
      • +8 more
      May 30, 2021

      Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome Trial in Rome (Aldurazyme (laronidase))

      Recruiting
      • Mucopolysaccharidosis I
      • +3 more
      • Aldurazyme (laronidase)
      • Rome, Italy
        Dipartimento di Scienze Pediatriche Medico - Chirurgiche e Neuro
      Mar 28, 2022

      Hurler's Syndrome, Maroteaux-Lamy Syndrome, Sly Syndrome Trial in Minneapolis (Stem Cell Transplantation, Cyclophosphamide,

      Terminated
      Has Results
      • Hurler's Syndrome
      • +10 more
      • Stem Cell Transplantation
      • +3 more
      • Minneapolis, Minnesota
        University of Minnesota, Fairview
      Dec 3, 2017

      Mucopolysaccharidosis Type IIIA Trial in Manchester (Autologous CD34+ cells transduced with a lentiviral vector containing the

      Active, not recruiting
      • Mucopolysaccharidosis Type IIIA
      • Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene
      • Manchester, United Kingdom
        Manchester University NHS Foundation Trust
      Jul 2, 2021

      Breast Cancer, Adherence, Medication, Side Effect Trial in New Haven (BETA-Text text messaging intervention)

      Active, not recruiting
      • Breast Cancer
      • +2 more
      • BETA-Text text messaging intervention
      • New Haven, Connecticut
        Yale Cancer Center
      Aug 10, 2022

      Gingival Recession Trial in Iowa City (Gum Graft Placed on Denuded Bone, Gum Graft Placed on Split Thickness Periosteal Bed

      Not yet recruiting
      • Gingival Recession
      • Gum Graft Placed on Denuded Bone
      • Gum Graft Placed on Split Thickness Periosteal Bed Preparation
      • Iowa City, Iowa
        University of Iowa College of Dentistry and Dental Clinics
      Jan 4, 2023

      Patients With Recessive Dystrophic Epidermolysis Bullosa

      Recruiting
      • Epidermolysis Bullosa Dystrophica
        • Stanford, California
          Stanford University School of Medicine
        Mar 17, 2021

        Trauma Trial (4 factor Prothrombin Complex Concentrates)

        Not yet recruiting
        • Trauma
        • 4 factor Prothrombin Complex Concentrates
        • (no location specified)
        Feb 21, 2023

        Neurodevelopmental Status in Pediatric Hunter Syndrome (MPS II)

        Completed
        • Mucopolysaccharidosis (MPS)
        • Hunter Syndrome
          • Oakland, California
          • +6 more
          Mar 15, 2021

          Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

          Recruiting
          • Metastatic or Locally Advanced Malignancies
          • Berlin, Germany
          • +5 more
          Jan 2, 2023

          Coronary Disease, Myocardial Infarction Trial in Oslo, Trondheim (Tocilizumab, Sodium chloride 0.9%)

          Completed
          • Coronary Disease
          • Myocardial Infarction
          • Oslo, Norway
          • +2 more
          Feb 28, 2021

          Breast Tumor, Primary Prevention, Risk Factors Trial in Oviedo (Web access)

          Completed
          • Breast Neoplasm
          • +3 more
          • Web access
          • Oviedo, Asturias, Spain
            Universidad de Oviedo
          Jul 11, 2022

          Technology Trial in Hong Kong (Experimental group intervention, Control group intervention)

          Recruiting
          • Technology
          • Experimental group intervention
          • Control group intervention
          • Hong Kong, Hong Kong
          • +1 more
          Jun 20, 2022

          Based on Smartphone-derived Multimodality Images to Evaluate

          Recruiting
          • Portal Hypertension
          • Hepatic venous pressure gradient
          • Beijing, Beijing, China
          • +1 more
          May 30, 2022

          Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa Trial in Stanford (LZRSE-Col7A1 Engineered Autologous Epidermal Sheets)

          Active, not recruiting
          • Epidermolysis Bullosa Dystrophica
          • Epidermolysis Bullosa
          • LZRSE-Col7A1 Engineered Autologous Epidermal Sheets
          • Stanford, California
            Stanford University School of Medicine
          Oct 23, 2020

          Prothrombin Complex Factor Deficiency Trial in Austria, Hungary (Prothrombin complex concentrate (coagulation factors IX, II,

          Completed
          • Prothrombin Complex Factor Deficiency
          • Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination)
          • Feldkirch, Austria
          • +5 more
          Apr 30, 2021

          Myozyme® and of Aldurazyme® in Male and Female Participants of

          Recruiting
          • Pompe Disease
          • Mucopolysaccharidosis Type I (MPS I)
            • Italy, Italy
              Investigational site Italy
            May 3, 2022

            Taste Disturbance After Middle Ear Surgery: Frequency, Duration,

            Not yet recruiting
            • Ear Middle Problems
            • Questionnaire
            • Nice, France
              CHU de Nice
            May 19, 2021

            Cardiac Allograft Vasculopathy Trial in Denmark, Finland, Sweden (Evolocumab, Placebo)

            Recruiting
            • Cardiac Allograft Vasculopathy
            • Copenhagen, Denmark
            • +4 more
            Feb 25, 2021

            RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A

            Recruiting
            • Acute Mountain Sickness
            • +2 more
              • Jomsom, Gandaki, Nepal
                Mustang District Hospital
              Sep 9, 2023

              MPS III B, Mucopolysaccharidosis Type IIIB Trial in Worldwide (AX 250)

              Completed
              • MPS III B
              • Mucopolysaccharidosis Type IIIB
              • AX 250
              • Oakland, California
              • +6 more
              Aug 4, 2020